Institutional investors purchased a net $1.9 million shares of ILMN during the quarter ended December 2016 and now own 94.83% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 2.1 Million shares of Illumina Inc
EDGEWOOD MANAGEMENT LLC Bought 1.7 Million shares of Illumina Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 488.2 Thousand shares of Illumina Inc